After Heparin: - The Pew Charitable Trusts

PHARMACEUTICAL MANUFACTURING: GLOBALIZATION AND QUALITY MANAGEMENT
Figure 6
Outsourced active-ingredient manufacturing revenue: growth by region
$35 BILLIONS OF DOLLARS
30
25
U.S. India Europe Rest of the World
20
15
10
5
0
2007 2008 2009 2014
(projected)
Source of original data: BCC Research. 106
Figure 7
Outsourced finished drug manufacturing revenue: growth by region
$40 BILLIONS OF DOLLARS
35
30
25
20
15
10
5
0
2007 2008 2009 2014
(projected)
Source of original data: BCC Research. 107
Emerging economies play increasingly larger roles in the U.S. drug supply. According to an analysis of
import data from the U.S. Census Bureau’s Foreign Trade Division, of the top 12 source countries for
imported pharmaceuticals and medicines * by weight in 2009, four were emerging or developing economies:
China, India, Brazil and Mexico. 108 The United States imported more than 80 million kilograms of
pharmaceuticals and medicines from China in 2009 (see figure 8), by far the largest amount from any
country that year and representing more than 20 percent of all imported pharmaceuticals and medicines
into the United States by weight. 109 Pharmaceuticals and medicines from India were the third most imported
by weight in 2009, after Canada, and showed tremendous growth in this period—approximately
30 million kilograms in 2009, compared with less than 5 million kilograms a decade earlier. Imports
35
30
* The category of pharmaceuticals and medicines is so defined by the North American Industry Classification System (NAICS). NAICS 3254:
Pharmaceuticals and medicines may include substances for both human and veterinary use.
After Heparin: PRotecting Consumers from the Risks of Substandard and Counterfeit Drugs 23
25
20
15